| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.012 | 1 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |